DS
MDGL icon

David Shaw’s Madrigal Pharmaceuticals MDGL Stock Holding History

David Shaw’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Hold
19,500
– – 0.01% 1771
2026
Q1 		$10.2M Sell
19,500
-7,800
-29% -$3.73M 0.01% 1621
2025
Q4 		$15.9M Buy
27,300
+2,600
+11% +$1.33M 0.01% 1391
2025
Q3 		$11.3M Buy
24,700
+16,100
+187% +$6.01M 0.01% 1580
2025
Q2 		$2.6M Buy
8,600
+100
+1% +$29.8K ﹤0.01% 2548
2025
Q1 		$2.82M Hold
8,500
– – ﹤0.01% 2347
2024
Q4 		$2.62M Buy
+8,500
New +$2.39M ﹤0.01% 2515
2024
Q3 		– Sell
-900
Closed -$252K – 4747
2024
Q2 		$252K Sell
900
-8,200
-90% -$1.95M ﹤0.01% 3980
2024
Q1 		$2.43M Buy
+9,100
New +$2.14M ﹤0.01% 2478
2021
Q4 		– Sell
-10,000
Closed -$798K – 5575
2021
Q3 		$798K Hold
10,000
– – ﹤0.01% 3777
2021
Q2 		$974K Buy
10,000
+6,200
+163% +$734K ﹤0.01% 3565
2021
Q1 		$444K Buy
+3,800
New +$443K ﹤0.01% 3557
2020
Q1 		– Sell
-10,000
Closed -$911K – 4118
2019
Q4 		$911K Sell
10,000
-10,000
-50% -$970K ﹤0.01% 3056
2019
Q3 		$1.72M Sell
20,000
-10,000
-33% -$938K ﹤0.01% 2468
2019
Q2 		$3.14M Buy
30,000
+9,200
+44% +$985K ﹤0.01% 1930
2019
Q1 		$2.6M Buy
20,800
+10,000
+93% +$1.24M ﹤0.01% 1977
2018
Q4 		$1.22M Buy
+10,800
New +$1.67M ﹤0.01% 2527

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's MDGL Position: Q2 2026 in Review

David Shaw increased its Madrigal Pharmaceuticals (MDGL) stake by 16% in Q2 2026, buying an estimated $2.53M and bringing the position to 35,071 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #1322.

David Shaw first reported a position in MDGL in Q2 2013 and has held it in 40 quarters since. The position peaked at $51.6M in Q4 2025. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • David Shaw held 35,071 shares of Madrigal Pharmaceuticals worth $18.8M as of Q2 2026.
  • David Shaw bought 4,932 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.53M.
  • Madrigal Pharmaceuticals made up 0.01% of David Shaw's portfolio in Q2 2026, its #1322 holding.
  • David Shaw first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • David Shaw's Madrigal Pharmaceuticals position peaked at $51.6M in Q4 2025.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.